|
AMMECR1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.274790E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.874450E-02 |
| Normal-vs-Stage2 |
4.184400E-01 |
| Normal-vs-Stage3 |
7.908200E-01 |
| Normal-vs-Stage4 |
6.075600E-01 |
| Stage1-vs-Stage2 |
6.356000E-01 |
| Stage1-vs-Stage3 |
2.297200E-01 |
| Stage1-vs-Stage4 |
1.126370E-01 |
| Stage2-vs-Stage3 |
6.383600E-01 |
| Stage2-vs-Stage4 |
3.297600E-01 |
| Stage3-vs-Stage4 |
4.983400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.715600E-02 |
| Normal-vs-AfricanAmerican |
4.197000E-01 |
| Normal-vs-Asian |
6.133600E-01 |
| Caucasian-vs-AfricanAmerican |
6.488800E-01 |
| Caucasian-vs-Asian |
8.571400E-01 |
| AfricanAmerican-vs-Asian |
9.824800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.548080E-02 |
| Normal-vs-Female |
3.403600E-01 |
| Male-vs-Female |
1.720870E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.134400E-02 |
| Normal-vs-Extreme_Weight |
3.262900E-03 |
| Normal-vs-Obese |
8.489600E-01 |
| Normal-vs-Extreme_Obese |
6.509400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.665000E-01 |
| Normal_Weight-vs-Obese |
1.417440E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.674400E-01 |
| Extreme_Weight-vs-Obese |
1.976440E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.608400E-01 |
| Obese-vs-Extreme_Obese |
7.551600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.676500E-02 |
| Normal-vs-Age(41-60Yrs) |
7.818000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.078600E-03 |
| Normal-vs-Age(81-100Yrs) |
8.517700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.972300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.720000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.179930E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.321200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.581700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.925400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.357400E-01 |
| Normal-VS-Type2 PRCC |
1.800060E-03 |
| Normal-VS-KIRP CIMP |
6.517600E-02 |
| Normal-VS-Unclassified PRCC |
7.183000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.610300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.386180E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.495200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.387200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.782200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.812210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.438790E-03 |
| Normal-vs-N1 |
2.188400E-01 |
| Normal-vs-N2 |
3.537700E-02 |
| N0-vs-N1 |
7.539600E-03 |
| N0-vs-N2 |
4.335800E-03 |
| N1-vs-N2 |
7.066400E-01 |
|
|
